Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: saying (165)

Endovascular aneurysm repair (EVAR) - patient information

Description: Information about endovascular aneurysm repair (EVAR
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Endovascular-aneurysm-repair-EVAR-1657-PIL.pdf

Angiogram and angioplasty - patient information

Description: Information about angiogram to assess the blood flow into your leg and angioplasty to improve the blood flow.
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Angiogram-and-angioplasty-1655-PIL.pdf

Abdominal aortic aneurysm repair - patient information

Description: Information about abdominal aortic aneurysm repair
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Abdominal-aortic-aneurysm-repair-1654-PIL.pdf

Endometrial-Dostarlimab

Description: Chemotherapy Protocol GYNACOLOGICAL CANCER Dostarlimab Regimen  Endometrial - Dostarlimab Indication  Dostarlimab is indicated for patients with; - proven histological diagnosis of endometrial carcinoma
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/Dostarlimab.pdf

Total body irradiation (TBI) - patient information

Description: This factsheet explains what to expect at your TBI treatment appointments.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Total-body-irradiation-TBI-1332-PIL.pdf

Bronchoscopy (surgical) - patient information

Description: This factsheet contains information about having a bronchoscopy (surgical).
Url: /Media/UHS-website-2019/Patientinformation/Cardiovascular-and-thoracic/Bronchoscopy-surgical-3130-PIL.pdf

Charitable Funds Committee ToR April 2022

Description: Charitable Funds Committee Terms of Reference Date Issued: Review Date: Document Type: 28 April 2022 April 2023 Committee Terms of Reference
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Charitable-Funds-Committee-ToR-April-2022.pdf

DVdSC (weekly cycles 9 onwards) DaratumumabSC-Bortezomib-Dexamethasone Ver1

Description: Chemotherapy Protocol Myeloma DVd SC (weekly) Bortezomib Daratumumab Dexamethasone Cycles 9 onwards Regimen • Myeloma – Bortezomib with daratumumab and dexamethasone Indication • Daratumumab
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVdSC-weekly-cycles-9-onwards-DaratumumabSC-Bortezomib-Dexamethasone-Ver1.pdf

Durvalumab_14day

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Durvalumab (14 day) Regimen • NSCLC - Durvalumab (14 day) Indication • Stage 3 NSCLC after
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Durvalumab-14day.pdf

Durvalumab(28day-1500mg)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) Durvalumab (28 day – 1500mg) Regimen • NSCLC - Durvalumab (28 day – 1500mg) Indication • Durvalumab is
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Durvalumab28day-1500mg.pdf

381 to 390 of 463

Previous … 37 38 39 40 41 … Next